These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26110507)

  • 1. Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin.
    Bunger JC; Melton-Celsa AR; Maynard EL; O'Brien AD
    Toxins (Basel); 2015 Jun; 7(6):2306-20. PubMed ID: 26110507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching Shiga Toxin (Stx) Type from Stx2d to Stx2a but Not Stx2c Alters Virulence of Stx-Producing
    McNichol BA; Bova RA; Torres K; Preston LN; Melton-Celsa AR
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33467588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Shiga toxin type 2d (Stx2d) by elastase involves cleavage of the C-terminal two amino acids of the A2 peptide in the context of the appropriate B pentamer.
    Melton-Celsa AR; Kokai-Kun JF; O'Brien AD
    Mol Microbiol; 2002 Jan; 43(1):207-15. PubMed ID: 11849548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stx2 subtyping of Shiga toxin-producing Escherichia coli isolated from cattle in France: detection of a new Stx2 subtype and correlation with additional virulence factors.
    Bertin Y; Boukhors K; Pradel N; Livrelli V; Martin C
    J Clin Microbiol; 2001 Sep; 39(9):3060-5. PubMed ID: 11526129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virulence Potential of Activatable Shiga Toxin 2d-Producing Escherichia coli Isolates from Fresh Produce.
    Melton-Celsa AR; O'Brien AD; Feng PC
    J Food Prot; 2015 Nov; 78(11):2085-8. PubMed ID: 26555533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AB5 Preassembly Is Not Required for Shiga Toxin Activity.
    Pellino CA; Karve SS; Pradhan S; Weiss AA
    J Bacteriol; 2016 Jun; 198(11):1621-1630. PubMed ID: 27002129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activatable Shiga toxin 2d (Stx2d) in STEC strains isolated from cattle and sheep at slaughter.
    Tasara T; Bielaszewska M; Nitzsche S; Karch H; Zweifel C; Stephan R
    Vet Microbiol; 2008 Sep; 131(1-2):199-204. PubMed ID: 18417300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.
    Friedrich AW; Bielaszewska M; Zhang WL; Pulz M; Kuczius T; Ammon A; Karch H
    J Infect Dis; 2002 Jan; 185(1):74-84. PubMed ID: 11756984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time PCR assays to detect 10 Shiga toxin subtype (Stx1a, Stx1c, Stx1d, Stx2a, Stx2b, Stx2c, Stx2d, Stx2e, Stx2f, and Stx2g) genes.
    Harada T; Wakabayashi Y; Seto K; Lee K; Iyoda S; Kawatsu K
    Diagn Microbiol Infect Dis; 2023 Mar; 105(3):115874. PubMed ID: 36529020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between stx genotype and Stx2 expression level in Shiga toxin-producing Escherichia coli O157 strains.
    Kawano K; Ono H; Iwashita O; Kurogi M; Haga T; Maeda K; Goto Y
    Jpn J Infect Dis; 2012 Jul; 65(4):322-5. PubMed ID: 22814156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shiga toxin subtypes display dramatic differences in potency.
    Fuller CA; Pellino CA; Flagler MJ; Strasser JE; Weiss AA
    Infect Immun; 2011 Mar; 79(3):1329-37. PubMed ID: 21199911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of native Shiga toxins (Stxs) type 1 and 2 with chimeric toxins indicate that the source of the binding subunit dictates degree of toxicity.
    Russo LM; Melton-Celsa AR; Smith MJ; O'Brien AD
    PLoS One; 2014; 9(3):e93463. PubMed ID: 24671194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional analysis of genes encoding Shiga toxin 2 and its variants in Escherichia coli.
    Zhang W; Bielaszewska M; Friedrich AW; Kuczius T; Karch H
    Appl Environ Microbiol; 2005 Jan; 71(1):558-61. PubMed ID: 15640236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a homogeneous time-resolved FRET (HTRF) assay for the quantification of Shiga toxin 2 produced by
    Nakamura K; Tokuda C; Arimitsu H; Etoh Y; Hamasaki M; Deguchi Y; Taniguchi I; Gotoh Y; Ogura Y; Hayashi T
    PeerJ; 2021; 9():e11871. PubMed ID: 34395095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome.
    Bielaszewska M; Friedrich AW; Aldick T; Schürk-Bulgrin R; Karch H
    Clin Infect Dis; 2006 Nov; 43(9):1160-7. PubMed ID: 17029135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-step purification and molecular characterization of functional Shiga toxin 2 variants from pathogenic Escherichia coli.
    He X; Quiñones B; McMahon S; Mandrell RE
    Toxins (Basel); 2012 Jul; 4(7):487-504. PubMed ID: 22852065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity-Based Screening of Tetravalent Peptides Identifies Subtype-Selective Neutralizers of Shiga Toxin 2d, a Highly Virulent Subtype, by Targeting a Unique Amino Acid Involved in Its Receptor Recognition.
    Mitsui T; Watanabe-Takahashi M; Shimizu E; Zhang B; Funamoto S; Yamasaki S; Nishikawa K
    Infect Immun; 2016 Sep; 84(9):2653-61. PubMed ID: 27382021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of the Ridascreen Verotoxin enzyme immunoassay for detection of Shiga-toxin producing strains of Escherichia coli (STEC) from food and other sources.
    Beutin L; Steinrück H; Krause G; Steege K; Haby S; Hultsch G; Appel B
    J Appl Microbiol; 2007 Mar; 102(3):630-9. PubMed ID: 17309611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shiga toxin 2 subtypes of enterohemorrhagic E. coli O157:H- E32511 analyzed by RT-qPCR and top-down proteomics using MALDI-TOF-TOF-MS.
    Fagerquist CK; Zaragoza WJ
    J Am Soc Mass Spectrom; 2015 May; 26(5):788-99. PubMed ID: 25667061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycan encapsulated gold nanoparticles selectively inhibit shiga toxins 1 and 2.
    Kulkarni AA; Fuller C; Korman H; Weiss AA; Iyer SS
    Bioconjug Chem; 2010 Aug; 21(8):1486-93. PubMed ID: 20669970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.